Month: September 2022

Data include the persistence of immune responses and protection against variants of concern, especially Delta and OmicronOcugen has North American commercialization rights for BBV152, commercialized as COVAXIN™MALVERN, Pa., Sept. 14, 2022 (GLOBE NEWSWIRE) — Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a biotechnology company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines, today announced the publication “A comprehensive review of BBV152 vaccine development, effectiveness, safety, challenges, and prospects” appeared in Frontiers in Immunology. BBV152, commercialized as COVAXIN™, is developed and manufactured by Ocugen’s partner Bharat Biotech, a global leader in vaccine innovation based in Hyderabad, India. BBV152 is currently authorized by the World Health Organization,...

XCPCNL Business Services invites individual and institutional investors as well as advisors and analysts, to attend its real-time, interactive presentation at the Emerging Growth Conference Charlotte, North Carolina, Sept. 14, 2022 (GLOBE NEWSWIRE) — XCPCNL Business Services Corporation (OTC Pink: XCPL), a venture development business that leverages knowledge, skill, and experience in the consumer products industry (the “Company”) is pleased to announce that it has been invited to present at the Emerging Growth Conference on September 14, 2022. The next Emerging Growth Conference is presenting on September 14, 2022.  This live, interactive online event will give existing shareholders and the investment community the opportunity to interact with the Company’s CEO, Tim Matthews in real time. Mr. Matthews will perform a presentation...

TORONTO, Sept. 14, 2022 (GLOBE NEWSWIRE) — POET Technologies Inc. (“POET” or the “Company”) (TSX Venture: PTK; NASDAQ: POET), the designer and developer of the POET Optical Interposer™ and Photonic Integrated Circuits (PICs) for the data center and tele-communication markets, today announced that representatives from the Company will participate at the 2022 European Conference on Optical Communication (ECOC), which will be held September 18-22, 2022 in Basel, Switzerland. The Company will also be exhibiting in booth 578. ECOC is the continent’s largest event in the field and one of the most prestigious events on optical communications worldwide. Dr. Simon Goh, principal engineer, will present his paper on the passive alignment of lasers on the POET Optical Interposer in the session, “Non-Linear Devices and Packaging”, on...

American Rebel Holdings Inc EV Bikes – American Rebel – Rebel 1000Nashville, TN, Sept. 14, 2022 (GLOBE NEWSWIRE) — American Rebel Holdings, Inc. (NASDAQ: AREB) – America’s Patriotic Brand (the “Company”) announces signing a letter of intent with Deerfield, Florida based Sierra E-Life, a full-service USA manufacturer of E-Bikes. “We are very excited to diversify our product offerings, thereby enhancing American Rebel as a lifestyle brand, by entering the futuristic, technology-savvy market of E-Bikes,” said American Rebel CEO Andy Ross. “We think the E-Bike market is ready for the E-Bike with an attitude! American Rebel’s grit, style and patriotic appeal will carry through to every product we design and put the American Rebel name on.” American Rebel, in collaboration with Sierra E-Life, has designed three distinct...

Clinical Leadership and Management Call to Follow Sunnyvale, Calif., Sept. 14, 2022 (GLOBE NEWSWIRE) — BioCardia®, Inc. [Nasdaq: BCDA], a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today announces that new data from its CardiAMP® Cell Therapy for Heart Failure pivotal trial (ClinicalTrials.gov Identifier: NCT02438306), will be presented at the Heart Failure Society of America (HFSA) Annual Meeting on October 1, 2022 at 6:00pm titled, “Autologous Cell Therapy For HFrEF: Efficacy Outcomes at Two Years for The Roll-in Cohort of a Phase III Pivotal Trial.” This year’s HFSA meeting provides a hybrid format; in-person at the Gaylord National Harbor in Washington, D.C., or global live on-line access. This data from the CardiAMP Cell Therapy Heart Failure trial will be...

SHANGHAI, China, Sept. 14, 2022 (GLOBE NEWSWIRE) — Q&K International Group Limited (NASDAQ: QK) (the “Company”), a leading technology-driven long-term apartment rental platform in China, today announced the results of its 2022 annual general meeting held in Shanghai on September 13, 2022. Specifically, the shareholders have approved:the change of the Company’s name from “Q&K INTERNATIONAL GROUP LIMITED” to “FLJ Group Limited”; and the amendment to the Company’s amended and restated memorandum and articles of association of the Company to reflect the change in Company’s name.Accordingly, the Company has changed its corporate name from “Q&K International Group Limited” to “FLJ Group Limited”, effective on September 13, 2022. In addition, the Company expects to begin trading under the new ticker symbol “FLJ” on...

MALVERN, Pa., Sept. 14, 2022 (GLOBE NEWSWIRE) — Vishay Precision Group, Inc. (NYSE: VPG), a leader in precision measurement sensing technologies, announced that the company will present at the Sidoti Small-Cap Virtual Conference on Wednesday, September 21, 2022 at 10:45 a.m. ET. A live and on-demand webcast of VPG’s presentation will be available to the public and can be accessed from the following link: VPG_Presentation_2022_Sidoti_Conference, or on VPG’s website: ir.vpgsensors.com/events. For more information, or for help in arranging a one-on-one meeting at the conference, please contact: info@vpgsensors.com. About VPG Vishay Precision Group, Inc. (VPG) is a leader in precision measurement sensing technologies. Our sensors, weighing solutions and measurement systems optimize and enhance our customers’ product performance across...

BOCA RATON, Fla., Sept. 14, 2022 (GLOBE NEWSWIRE) — First Wave BioPharma, Inc., (NASDAQ: FWBI), (“First Wave BioPharma” or the “Company”), a clinical-stage biopharmaceutical company specializing in the development of targeted, non-systemic therapies for gastrointestinal (GI) diseases, today announced that James Sapirstein, Chairman, President, and CEO of First Wave BioPharma, will moderate a panel discussion on drug development during the Longwood Healthcare Leaders Fall Webconference taking place September 21-22, 2022. The panel, titled, “Accelerating Drug Development,” will include Christian Antoni, Chief Development Officer, EQRx; Matt Gevaert, CEO, Kiyatec; Priya Singhal, Interim Head of R&D, SVP, Global Head, Safety & Regulatory Sciences, Biogen; and Pamela Stetkiewicz, Chief Operating Officer, Arbor Biotechnologies. Details...